796 related articles for article (PubMed ID: 15286322)
1. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis.
Sabeti S; Schillinger M; Amighi J; Sherif C; Mlekusch W; Ahmadi R; Minar E
Radiology; 2004 Aug; 232(2):516-21. PubMed ID: 15286322
[TBL] [Abstract][Full Text] [Related]
2. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries.
Sabeti S; Mlekusch W; Amighi J; Minar E; Schillinger M
J Endovasc Ther; 2005 Feb; 12(1):6-12. PubMed ID: 15683273
[TBL] [Abstract][Full Text] [Related]
3. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
[TBL] [Abstract][Full Text] [Related]
4. Primary nitinol stenting for femoropopliteal disease.
Mewissen MW
J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II63-81. PubMed ID: 19624075
[TBL] [Abstract][Full Text] [Related]
5. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
7. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.
Goltz JP; Ritter CO; Kellersmann R; Klein D; Hahn D; Kickuth R
J Endovasc Ther; 2012 Jun; 19(3):450-6. PubMed ID: 22788900
[TBL] [Abstract][Full Text] [Related]
8. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes after percutaneous peripheral intervention for chronic total occlusion of superficial femoral arteries: comparison between self-expandable nitinol stent and stainless steel stent.
Nakagawa Y; Yajima J; Oikawa Y; Ogasawara K; Kirigaya H; Nagashima K; Funada R; Matsuno S; Inaba T; Nakamura M; Sawada H; Aizawa T
J Cardiol; 2009 Jun; 53(3):417-21. PubMed ID: 19477385
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors of femoropopliteal patency after suboptimal duplex-guided balloon angioplasty and stenting: is recoil a bad sign?
Ascher E; Hingorani AP; Marks N; Puggioni A; Shiferson A; Tran V; Jacob T
Vascular; 2008; 16(5):263-8. PubMed ID: 19238867
[TBL] [Abstract][Full Text] [Related]
11. Outcome after nitinol stenting in the superficial femoral and popliteal artery in an elderly population.
Gillgren P; Pettersson H; Fernström J; Falkenberg M; Delle M; Konrad P; Lindström D
Ann Vasc Surg; 2011 Aug; 25(6):758-65. PubMed ID: 21439769
[TBL] [Abstract][Full Text] [Related]
12. Incidence of stent fractures and patency after femoropopliteal stenting with the nitinol self-expandable SMART stent: a single-center study.
Trabattoni D; Agrifoglio M; Cappai A; Bartorelli AL
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):678-82. PubMed ID: 20216226
[TBL] [Abstract][Full Text] [Related]
13. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
Chan YC; Cheng SW; Cheung GC
J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
[TBL] [Abstract][Full Text] [Related]
14. Strecker stents in the femoropopliteal arteries: value of duplex ultrasonography in restenosis assessment.
Bray AE; Liu WG; Lewis WA; Harrison C; Maullin A
J Endovasc Surg; 1995 May; 2(2):150-60. PubMed ID: 9234128
[TBL] [Abstract][Full Text] [Related]
15. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
[TBL] [Abstract][Full Text] [Related]
16. Evolving modalities for femoropopliteal interventions.
Ansel GM; Lumsden AB
J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
[TBL] [Abstract][Full Text] [Related]
17. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis.
Iida O; Soga Y; Hirano K; Suzuki K; Yokoi H; Nobuyoshi M; Muramatsu T; Inoue N; Nanto S; Uematsu M
J Endovasc Ther; 2011 Dec; 18(6):753-61. PubMed ID: 22149222
[TBL] [Abstract][Full Text] [Related]
19. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia.
Kickuth R; Keo HH; Triller J; Ludwig K; Do DD
J Vasc Interv Radiol; 2007 Jun; 18(6):703-8. PubMed ID: 17538131
[TBL] [Abstract][Full Text] [Related]
20. Below-knee bare nitinol stent placement in high-risk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice.
Donas KP; Schwindt A; Schönefeld T; Tessarek J; Torsello G
Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):688-93. PubMed ID: 19328021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
